card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
hero-bg-3211_Scientist wearing safety glasses

Bioanalytical Services

High-Throughput ADME Services

Capabilities that accelerate preclinical studies

In vitro ADME screening during the lead optimization stage of drug discovery positively impacts drug candidate selection with an enhanced probability of success in clinical trials. Since most new drug candidates fail during preclinical and clinical development, and the late stage of the drug development cycle can be a lengthy and costly process, any means of identifying drug candidates with optimized ADME and pharmacokinetics properties in the discovery stage will have a significant impact on the drug discovery process overall.

IQVIA Laboratories highly automated in vitro ADME laboratory partners with small, mid and large pharmaceutical customers around the world to perform large scale ADME screening assays using in-house or client-customized protocols. Our rapid ADME assay development turnaround time enables parallel optimization of the ADME properties of your chemical platform, alongside your potency and selectivity targets, thereby enabling you to make important decisions about your potential candidates.

Partner with us for your preclinical ADME screening needs to realize:

  • Increased Speed: Establishment of high-throughput ADME assays allows for the prioritization of your drug candidates by their ADME properties in parallel with optimization of their efficacy at early discovery phases. This approach improves the overall quality of your drug candidates and the probability of their success, thereby shortening the drug discovery and development process.
  • Reduced Cost and Development Cycle Times: We generate in vitro screening data that customers can use in their in-silico models. This combination of in vitro screening and in-silico alternatives helps customers generate ADME data that can lead to a reduction in animal studies, and a more efficient and potentially less expensive study.
  • Optimized Discovery Cycle Time: By ensuring that only the most promising candidates are progressed through to clinical trials, the drug discovery pipeline can become more streamlined and efficient once clinical trials begin. Optimizing drug leads early on reduces the cost and time of progressing unsuccessful compounds through to the later stages of development.
  • Detailed Dose Levels: Pharmacokinetic (PK) parameters are extrapolated from measurement of drug concentration in the plasma, blood, or other biological matrices over a selected time period. This provides information that can guide your future animal and clinical studies for the selection of the dose levels and frequency of administration.


Our experienced scientists perform a range of high-throughput screening services, routinely conducting industry-standard in vitro ADME assays and continuously developing novel in vitro assays to address current metabolism issues and the evolving needs of our customers.

 

The initiation of early ADME screening dramatically decreases the proportion of compounds failing in clinical trials. Our preclinical ADME screening services help customers eliminate weak drug candidates prior to clinical development, thereby helping them to focus their resources on potential drug candidates so that the right drugs get to the right patients faster and more efficiently.

Capacity and on-time delivery is critical to this process.

Related Services

card-3211_Scientist wearing safety glasses

ADME / DMPK Services

Learn more
card-3270_young woman scientist in laboratory working

Early Hit-to-Lead ADME Screening Bundle

Learn more
card-3222_Close up of test tubes with blood samples on stand

In Vitro Screening

Learn more
card-3241_Technician holding blood tube test in the research laboratory

Discovery Bioanalysis

Learn more
card-3255_Female Research Scientist Putting Test Tubes with Blood Samples into Analyzer

High-Throughput ADME Services

Learn more
card-3232_Laboratory assistant putting test tubes into the holder

In Vitro Metabolism

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

Assessing your Drug-Drug Interaction Testing Risk

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

ADME Assays & Metabolite Profiling and Identification Services

Learn more
card-3263_Hand in blue glove holding glass histology slides

Metabolite Identification and Profiling

Learn more
card-3229_test tubes for testing

Bioanalytical Services

Learn more
card-3259_man in laboratory with tablet for medical analysis

Small and Large Molecule LC-MS

Learn more

Related Insights

Managing Informed Consent Samples from Clinical Trials

A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials

Biorepository and Specimen Management

Your biological specimens are irreplaceable assets – trust them with a proven partner

ADME Services

Accelerating your drug discovery, preclinical and clinical programs

IQVIA Laboratories Central Laboratory Services

Central laboratory solutions supporting clinical trials around the world

Helping you master your lab data

Improved oversight with your lab data now in full view

NASH and Liver Disease Capabilities

Nonalcoholic Fatty Liver Diseases & Non-alcoholic Steatohepatitis (NAFLD & NASH)

How COVID-19 Changed Clinical Trial Dynamics and Environment

Precision Medicine World Conference 2021 Virtual Presentation

Pediatric Initiative

Optimizing small blood volumes to prevent canceled tests in clinical trials for pediatric patients

Vaccine Laboratory Services

Test Menu

SARS-CoV-2 Vaccine Induced Antibody Profiles

Presented at World Vaccine Congress 2021

See All